Uranium Energy’s Goliad ISR Uranium Project has been extensively explored and delineated in the past by previous owners. The first exploration activities began in the 1970s. When the company acquired the project, over 550 exploration holes had been drilled; however … Continue reading →

Majesco Entertainment Company (COOL), an innovative provider of video games for the mass market, announced the completion of the “Wonderworld Amusement Park” game for Nintendo Wii. This game, developed by Coyote Console, has multiple themed areas that consist of vast … Continue reading →

Art Technology Group, Inc (ARTG) announced that a panel of luminaries and experts has been selected to judge entries for the first ATG e-Commerce Ingenuity Business Plan Competition. Confirmed judges include: • Gene Alvarez – Vice president of Gartner Research. … Continue reading →

Generex Biotechnology Corporation (GNBT), the leader in drug delivery for metabolic diseases affecting the inner lining of the mouth, announced that the Ministry of Health of the United Arab Emirates has issued a non-object letter regarding the importation of Generax’s … Continue reading →

EntreMed, Inc. (ENMD), a clinical-stage pharmaceutical company that develops medication for the treatment of cancer and inflammatory diseases, announced that the U.S. Food and Drug Administration accepted the company’s Investigational New Drug Application for their Panzem(R) (2-Methoxyestradiol or 2ME2) product. … Continue reading →

Imagine being the only girl with four brothers. That’s what life was like for Xerox CEO Anne Mulcahy. In fact, Anne’s parents always encouraged her to compete at the same level as the rest of her four brothers. And, through … Continue reading →

Reckitt Benckiser Plc (RB) has agreed to purchase U.S. cough and congestion medicine group Adams Respiratory Therapeutics (ARXT) for $60 a share, or $2.3 billion, in cash. This move will mark Reckitt’s entry into the U.S. healthcare market. Reckitt, the … Continue reading →

Pressure Biosciences, Inc. (NASDAQ: PBIO), a life sciences company based in Massachusetts, researches, develops, and commercializes on sample preparation systems. The company’s cornerstone is its pressure cycling technology (PCT) that has the ability to use hydrostatic pressure between ambient and … Continue reading →

After Redchip’s announcement this morning that Pressure BioSciences would be a featured company in their upcoming investor conference, prices surged to reach a High-of-Day at $6.82, which is 18.2% higher than yesterday’s close. Volume also exploded reaching a 852% increase … Continue reading →

RedChip announced this morning that the CEOs and executive teams of 30 emerging small-cap companies will be presenting at this year’s RedChip Small-Cap Investor Conference at the Four Seasons Resort in Scottsdale, Arizona – Feb. 7, 2008, from 8 a.m. … Continue reading →